CRO

Unbounce Introduces the First Conversion Intelligence Platform, Ushering in a New Era of Digital Marketing for Small and Midsize Businesses

Wednesday, September 22, 2021 - 5:00pm

The Unbounce Conversion Intelligence Platform expands the companys offerings beyond landing pages and is designed to meet the needs of small and midsize businesses (SMBs).

Key Points: 
  • The Unbounce Conversion Intelligence Platform expands the companys offerings beyond landing pages and is designed to meet the needs of small and midsize businesses (SMBs).
  • The platform pairs a marketers intelligence with machine learning to increase the conversion rates of marketing campaigns at every touchpoint.
  • In a recent survey of marketers conducted on LinkedIn, Unbounce identified small business marketers' desire for more conversion growth as their top priority.
  • To answer this need, Unbounce created its new Conversion Intelligence Platform so SMBs can better compete against larger competitors and level up business growth.

MCRA Expands Neurology Division into Neurointerventional Market

Wednesday, September 22, 2021 - 3:15pm

Herrmann also had significant interactions onapplications for the clinical use ofdrug and biologic baseddevice combination products during his time with the agency.

Key Points: 
  • Herrmann also had significant interactions onapplications for the clinical use ofdrug and biologic baseddevice combination products during his time with the agency.
  • Dr. Herrmann said "I am very excited to join the highly distinguished team at MCRA and expand their regulatory expertise in the area of neurointerventional devices.
  • About MCRA, LLC:MCRA is the leading privately held independent medical device and biologics Clinical Research Organization (CRO) and advisory firm.
  • MCRA has offices in Washington, DC, Hartford, CT, and New York, NY, and serves more than 700 clients globally.

Investable Universe Launches Provocative Polar Futures Media Series

Wednesday, September 22, 2021 - 2:12pm

The real assets news site Investable Universe announces the launch of Polar Futures , a media series that examines the eight-nation Arctic regions growing geopolitical importance and its potential for attracting hundreds of billions of dollars in direct investment to develop the region and its bounty of natural resources.

Key Points: 
  • The real assets news site Investable Universe announces the launch of Polar Futures , a media series that examines the eight-nation Arctic regions growing geopolitical importance and its potential for attracting hundreds of billions of dollars in direct investment to develop the region and its bounty of natural resources.
  • Additionally, new trans-Arctic shipping lanes made more accessible by climate change will focus competing political and military interests on the polar zone.
  • The series also will include insights about the roles of Canada, Finland, Norway, Russia and Sweden in the rapidly evolving Arctic zone.
  • Trofast Medias Investable Universe provides leading edge insights into investment in real assets, the global market of things that spans traditional investments and emerging technologies on earth and in space.

New MMS SmartStart™ Tech-Enabled Solution Eases Document Content Creation Process

Wednesday, September 22, 2021 - 2:01pm

MMS Holdings Inc. (MMS) - an award-winning, data-focused CRO announced the release of SmartStart Tech-Enabled Templates to reduce time and effort in the document content creation process while increasing the quality of deliverables.

Key Points: 
  • MMS Holdings Inc. (MMS) - an award-winning, data-focused CRO announced the release of SmartStart Tech-Enabled Templates to reduce time and effort in the document content creation process while increasing the quality of deliverables.
  • SmartStart Templates apply structured authoring rules to the authoring process and include tech-enabled templates for protocols, statistical analysis plans (SAPs), and clinical study reports (CSRs).
  • The innovative technology of our SmartStart Templates will greatly reduce the time and effort needed when writing deliverables and bring therapies to patients quicker.
  • MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges.

American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute

Wednesday, September 22, 2021 - 1:00pm

Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute (Genesis), as a strategic research site.

Key Points: 
  • Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute (Genesis), as a strategic research site.
  • This new partnership with Sarah Cannon Research Institute will provide patients access to an expanded menu of clinical trials and advanced therapies.
  • The physicians at Genesis Cancer and Blood Institute are committed to delivering advanced treatment options for the best possible outcomes for their patients, said AON CEO Todd Schonherz.
  • About Sarah Cannon Research Institute: ( SarahCannon.com )
    Sarah Cannon Research Institute is the research arm of HCA Healthcares Cancer Institute, Sarah Cannon.

Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions

Tuesday, September 21, 2021 - 2:00pm

WEST LAFAYETTE, Ind. and INDIANAPOLIS, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contract research organization (CRO) specializing in nonclinical and analytical drug discovery and development services, and Envigo RMS Holding Corp. (or “Envigo”), a leading global provider of research models and services, today jointly announced that they have entered into an agreement for Inotiv to purchase Envigo. Upon consummation of the acquisition, which is subject to customary closing conditions, the combined company will enable drug developers to access products and services for the entirety of discovery and nonclinical development within one organization. Transaction consideration consists of $200 million of cash and 9,365,173 Inotiv common shares, subject to certain adjustments at closing. Inotiv has received committed debt financing to fund the cash portion of the transaction. Based upon the closing price of Inotiv common stock on Monday, September 20, 2021, the transaction values Envigo at an enterprise value of approximately $545 million, and the combined company at an enterprise value of approximately $1.2 billion.

Key Points: 
  • Transaction consideration consists of $200 million of cash and 9,365,173 Inotiv common shares, subject to certain adjustments at closing.
  • The complementary nature of Inotiv and Envigo is expected to accelerate the movement of innovative drugs and medical devices through the discovery and preclinical phases of development.
  • Supported by deep, in-house expertise and scientific capabilities, were building a comprehensive contract pharmaceutical research solutions provider with a full spectrum of discovery and nonclinical services and research models into a unique, one-stop-shop, discovery-to-approval solution for drug developers.
  • Envigo has a long history and broad expertise supplying critical research models and services to the scientific community, said Envigo CEO, Adrian Hardy .

Xevant Announces Key Additions to Its Executive Leadership Team

Tuesday, September 21, 2021 - 3:00pm

Jason's experience in managing teams and selling SaaS solutions over the past 15+ years has led to increasing combined valuations of $500M.

Key Points: 
  • Jason's experience in managing teams and selling SaaS solutions over the past 15+ years has led to increasing combined valuations of $500M.
  • "It's an exciting time to join Xevant with its current state of growth.
  • Lininger said, "I'm thrilled to join the Xevant team and look forward to contributing to a culture already set for success."
  • Xevant is the recipient of the Globee StartUp of The Year Award and is a certified Great Place to Work company.

Explora BioLabs Opens New Preclinical Vivarium in S. San Francisco, Calif.

Tuesday, September 21, 2021 - 3:26pm

The new vivarium, located in South San Francisco, East Side, is Explora BioLabs' sixth San Francisco facility (a seventh is expected to open in Dec. 2021).

Key Points: 
  • The new vivarium, located in South San Francisco, East Side, is Explora BioLabs' sixth San Francisco facility (a seventh is expected to open in Dec. 2021).
  • The facility allows researchers to focus on their science while Explora BioLabs' staff handles the preclinical in vivo management, husbandry, logistics, and compliance requirements.
  • Other facilities in Explora BioLabs' national network are distributed throughout California (San Francisco and San Diego) and Boston, Mass.
  • Explora BioLabs' national vivarium network provides biotechnology clients with on- and off-site vivarium services including vivarium management, facility design, rodent housing and equipment, supply chain management, regulatory oversight, and veterinary/husbandry staffing.

PureCars Appoints Guy Super As CRO, And Kate Colacelli As CMO

Tuesday, September 21, 2021 - 2:30pm

ATLANTA, Sept. 21, 2021 /PRNewswire/ --PureCars, a leading provider of digital marketing technology and services for automotive dealers, today announced the appointments of Guy Super as Chief Revenue Officer, and Kate Colacelli as Chief Marketing Officer.

Key Points: 
  • ATLANTA, Sept. 21, 2021 /PRNewswire/ --PureCars, a leading provider of digital marketing technology and services for automotive dealers, today announced the appointments of Guy Super as Chief Revenue Officer, and Kate Colacelli as Chief Marketing Officer.
  • Super is a proven leader, with a wealth of experience building, developing and managing strategic sales teams.
  • As PureCars' CRO, Super will drive sales acquisition efforts, while helping current automotive retail clients maximize the value derived from PureCars' digital advertising resources and solutions.
  • Colacelli joins PureCars after serving as Vice President of Marketing for Dealer-FX, a leading provider of automotive service lane technology.

LendingPoint Named Atlanta Inno Fire Award Recipient for Second Year

Tuesday, September 21, 2021 - 2:00pm

LendingPoint, the financial AI and technology platform, was recently named to the 2021 Atlanta Inno Fire Award list, a ranking showcasing the top tech startups and organizations setting Atlantas ecosystem ablaze.

Key Points: 
  • LendingPoint, the financial AI and technology platform, was recently named to the 2021 Atlanta Inno Fire Award list, a ranking showcasing the top tech startups and organizations setting Atlantas ecosystem ablaze.
  • Atlanta Innos annual award recognizes the top 50 organizations helping to establish Atlanta as an emerging tech hub and showcases the breadth of industries within the local tech scene.
  • LendingPoint has experienced significant growth during the past several years, which its leaders attribute to Atlantas thriving fintech environment.
  • LendingPoint was named one of the 2021 Best Places to Work by the Atlanta Business Chronicle.